Global Bioresorbable Coronary Stents Market Growth (Status and Outlook) 2023-2029

Global Bioresorbable Coronary Stents Market Growth (Status and Outlook) 2023-2029

Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these fully dissolvable stents that allow restoration of normal vasomotor function as well as normal vessel growth.

LPI (LP Information)' newest research report, the “Bioresorbable Coronary Stents Industry Forecast” looks at past sales and reviews total world Bioresorbable Coronary Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioresorbable Coronary Stents sales for 2023 through 2029. With Bioresorbable Coronary Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Coronary Stents industry.

This Insight Report provides a comprehensive analysis of the global Bioresorbable Coronary Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Coronary Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Coronary Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Coronary Stents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Coronary Stents.

The global Bioresorbable Coronary Stents market size is projected to grow from US$ 79 million in 2022 to US$ 142.4 million in 2029; it is expected to grow at a CAGR of 8.8% from 2023 to 2029.

APAC is expected to witness the fastest growth with a CAGR of 21%. Apart from increasing coronary stenting procedure volumes that stem from the high CVD-afflicted patient count, this region witnesses quick uptake of CE and FDA-approved devices, which in turn is engendering the high sales revenue of bioresorbable coronary stents in this regional segment.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Coronary Stents market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Absorb BVS
Absorb 2nd Generation
Magmaris
MeRes-100
DESolve

Segmentation by application
Hospital
Clinic
Research Institute

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BIOTRONIK
Meril Lifesciences Pvt. Ltd.
Elixir Medical Corporation
REVA Medical
Arterial Remodeling Technologies
Amaranth Medical
Microport Scientific Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.